Frontiers of Retrovirology 2013
The third biennial Frontiers of Retrovirology conference will be held from 16-18 September 2013 at Churchill College, Cambridge, UK.
Register you interest by emailing email@example.com
Following the success of the inaugural Frontiers of Retrovirology meeting in 2009, this second conference will bring together leading human retrovirus researchers to review current progress and to chart future challenges.
The research field of retrovirology is still booming. HIV affects 33 million individuals worldwide and 25 million have died from AIDS. A quarter of a century after the discovery of HIV-1, a curative or a vaccine strategy for AIDS remains elusive. The XMRV retrovirus of mouse origin has recently been implicated in diverse human diseases. HTLV and the oncogenic properties of diverse animal retroviruses remain an important topic of cancer research. The sequencing of several host genomes has provided an intriguing picture of the role played by endogenous retroviruses in genome evolution.
At Frontiers of Retrovirology 2011, internationally renowned speakers will present their insights into the principles guiding the life cycle of endogenous retroelements, complex human retroviruses, and their pathogenic interactions with the hosts.
All participants are invited to submit abstracts for oral and poster presentations. A significant number of talks will be selected from submitted abstracts.
Ben Berkhout, University of Amsterdam, Netherlands
Kuan-Teh Jeang, NIAID, Bethesda, USA and Editor-in-Chief, Retrovirology
Monique Nijhuis, University Medical Center Utrecht, Netherlands
Guido Vanham, Institute of Tropical Medicine Antwerp, Belgium
Frank Kirchhoff, University Hospital Ulm, Germany
Rogier Sanders, Cornell University, Ithaca, USA
Ariberto Fassati, University College London, UK
John M. Coffin - Tufts University, Boston, USA
From XMRV to HIV-1 and back
Jan Balzarini - Catholic University of Leuven, Belgium
Monsef Benkirane - Institut de Génétique Humaine CNRS, Montpellier, France
Hung Fan - University of California, Irvine, USA
Ariberto Fassati - University College London, UK
Masahiro Fujii - Niigata University, Japan
Teunis B.H. Geijtenbeek - University of Amsterdam, Netherlands
Gero Hütter - Heidelberg University, Mannheim, Germany
Kuan-Teh Jeang - NIAID, Bethesda, USA. Editor-in-Chief, Retrovirology
Frank Kirchhoff - University Hospital Ulm, Germany
Christine Kozak - NIAID, Bethesda, USA
Andrew M. Lever - University of Cambridge, UK
Michael H. Malim - King's College London, UK
Dusty Miller - Fred Hutchinson Cancer Research Center, Seattle, USA
Monique Nijhuis - University Medical Center Utrecht, Netherlands
Douglas Nixon - University of California, San Francisco, USA
William A. Paxton - University of Amsterdam, Netherlands
Rogier Sanders - Cornell University, Ithaca, USA
Olivier Schwartz - Institut Pasteur, Paris, France
Greg J. Towers - University College London, UK
Guido Vanham - Institute of Tropical Medicine Antwerp, Belgium
Mark Wainberg - McGill University AIDS Centre, Montreal, Canada
Kevin M. Weeks – University of North Carolina, Chapel Hill, USA
BioMed Central (http://www.biomedcentral.com) is an STM (Science, Technology and Medicine) publisher that has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.